ArticleJournal of thoracic disease2025

Phase 2 feasibility study of adjuvant chemotherapy with cisplatin (CDDP) and TS-1, followed by alternate-day TS-1 maintenance therapy, in patients with completely resected pathological stage II-IIIA non-small cell lung cancer.

Kosuke Fujino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.